Interestingly, although FHIT overexpression suppresses tumorigenicity both in vitro and in vivo, the hydrolase “dead” FHIT mutant also suppresses tumorigenicity in vivo [51], indicating that the hydrolase activity of FHIT is not required for tumor suppression. This evidence concerns the gene FHIT and neoplasm.